Abstract To assess a possible direct tubular action of a-human atrial natriuretic peptide (oc-hANP), we studied the effects of a-hANP on volume reabsorption (J~), transepithelial voltage (VT), and p-aminohippuric acid (PAH) secretion in the rabbit proximal straight tubules (PST) by in vitro microperfusion technique. In superficial PST (SFPST), addition of ahANP at various concentrations (10-v, 10 -9,10 -11 M) to the bath solution did not alter J~ significantly. Bath a-hANP (10 7M) did not change VT in SFPST, either. In juxtamedullary PST (JMPST), addition of a-hANP (10 7M) to the bath solution changed neither VT nor J~ significantly. The a-hANP (10 7M) in the luminal fluid caused no changes in either VT or J~ in SFPST. Furthermore, a-hANP (10-' M) in the bath did not change the rate of PAH secretion in SFPST. Thus, we could not obtain any evidence for direct tubular action of a-hANP in rabbit PST. Accordingly, a-hANP may increase solute excretion without directly affecting solutes transport in PST of the rabbit kidney.
Within the last few years, a natriuretic and vasodilatory substance derived from granules of mammalian atrial cardiocytes has been identified. Purification and amino acid sequence analysis has revealed that the substance is composed of varying chain length polypeptides (DE BOLD et al., 1981; FLYNN et al., 1983; CURRIE et al., 1984; KANGAWA and MATSUO, 1984; MISONO et al., 1984) . The general term "atrial natriuretic factor" (ANF) has been used to describe these polypeptides. a-Human atrial natriuretic polypeptide (a-hANP) was identified from human atrial tissue. It was demonstrated to be composed of 28 amino acids, the sequence of which resembles those derived from rat atrial tissues (KANGAWA and R. ANDO et al. MATSUO, 1984) . The mechanism of natriuresis induced by ANF is controversial. Changes in renal hemodynamics such as an increase in glomerular filtration rate (GFR), redistribution of renal blood flow, and an increase in renal blood flow (RBF), have been considered as mechanism of natriuresis (BoRENSTEIN et al., 1983; ATLAS et al., 1984; CAMARGO et al., 1984; MAACK et al., 1984; HIRATA et al., 1984; BEASLEY and MALVIN,1985; WAKITANI et a!., 1985) . On the other hand, several investigators have suggested that the natriuresis is mediated at least in part by a direct tubular action of ANF (BRIGGS et al., 1982; SONNENBERG et al., 1982; BURNETT et al., 1984; HAMMOND et al., 1985; SONNENBERG, 1985; YUKIMURA et al., 1985) .
Very recently, BAUM and TOTO (1986) reported using isolated tubule perfusion technique whereby 10-' M ANF added in the bath did not change volume flux (J~) or transepithelial potential difference (VT) in the rabbit PST and proximal convoluted tubles (PCT). In this study, the same technique was used and the dose of ANF was expanded (10 -'-10 -11 M). It is possible that the inhibitory effect of ANF is masked in a pharmacological dose (10 -' M) and it becomes apparent in a physiological dose (10 -9-10 -11 M). Furthermore, a possibility that ANF stimulates p-aminohippuric acid (PAH) secretion was tested because stimulation of PAH secretion has been shown to decrease J~ (GRANTHAM et al., 1974) .
MATERIALS AND METHODS
Isolated segments of the rabbit PST were dissected and perfused by a standard perfusion technique described by BURG et al. (1966) , with a slight modification (KUWAHARA et al., 1986) . Briefly, kidney slices from female Japanese white rabbits were prepared. Dissections were carried out in chilled bath solution (described below). The PST of superficial and juxtamedullary nephrons were selected at the time of dissection. After dissection, the tubules were transferred to a 1.0 ml thermostatically controlled bath. The two ends of the tubule were sucked into glass holding pipettes containing elastomeric silicone resin at the tips, providing a water and electrical seal. The perfusion pipette, previously centered, was advanced into the tubular lumen. Tubules were perfused. at 37°C at a perfusion rate of 7-15 nl/min. Solutions were synthetic ones. The perfusate contained in mM: Na,144; K, 5; Cl, 120; HCO3, 25; Ca, 1.8; P04, 2; Mg, l; glutamine, 5; alanine, 5; glucose, 5. The bath solution was similar to the perfusate except that 6 g/dl of dialyzed albumin (bovine, fraction V, Sigma) was added. The osmolalities of these solutions were adjusted to 295 mOsm/ kgH2O with either distilled water or the principal salt. These solutions were bubbled with 5 % C02/95% 02. To maintain bath pH constant during experiments, the bath was also continuously gassed with 5 % C02/95% 02.
The VT was measured using the perfusion pipette as a bridge into the tubular lumen. The perfusate and bath were connected to their respective calomel electrodes by 0.16 M NaCI-agar bridges. The J~ was measured using exhaustively dialyzed 
where VL is the collection rate, L is the length of the tubule, and CLC and CL; are the methoxy-[3H] inulin concentrations of the collected fluid and the initial perfusate, respectively. To examine the validity of our technique of measuring J~, 7 PST were perfused. The J, were determined in the control condition and in the experimental condition where 10 -5 M ouabain was added to the bath; J~ decreased significantly from 0.48 ± 0.10 to 0.08 + 0.05 nl/(mm . min) in response to ouabain addition. These values are comparable with the values previously reported by SCHAFER et al. (1974) , indicating the validity of our technique. PAH secretion was measured by adding [3H]-PAH (New England Nuclear, Boston, 5.2 Ci/mmol) to the bath, and by measuring the luminal appearance of [3H]-PAH. The secretion rate of PAH was calculated as
where JPAH is the secretion rate of PAH, VL is the collection rate, CL is the concentration of [3H]-PAH in the collected fluid, and S* is the specific activity of [3H]-PAH in the bath, and L is the length of the tubule, respectively. The general protocol was the same in all experiments. A 20-min equilibration time was allowed between periods in each protocol.
Group 1. The effects of adding synthetic a-hANP to the bath solutions on J~ and VT were examined in the superficial PST (SFPST) and juxtamedullary PST (JMPST). First, tubules were perfused and bathed with control solution. After an equilibrium period, timed collections were done. Then, synthetic a-hANP was added to the bath at the concentrations of 10 -', 10 -9, and 10 -11 M in SFPST and at 10 -' M in JMPST. After a 20-min incubation time, a second group of collections were made. Experiments usually contained a third (recovery) period in which the tubules were bathed again with control solution.
Ggroup 2. The effects of adding a-hANP to the luminal perfusate on J~ were examined in SFPST. After the control period, the perfusate was changed to a solution containing 10-' M a-hANP.
Group 3. The effects of adding 10-' M a-hANP to the bath solution on PAH secretion were examined in SFPST. This protocol also contained a control, experimental (a-hANP), and recovery period. Bath solution contained [3H]-PAH at a concentration of 10 RCi/ml. A chemical PAH concentration in the bath solution was adjusted to 24 mM by adding cold PAH.
A mean value for J~ and JPAH was determined from three individual collections during each period in a given tubule. The data are expressed as mean + S.E. (n, number of tubules). The Student's t-test for paired data was used to determine statistical significance.
The a-hANP used in this study was a synthetic one purchased from Peninsula Laboratories (California) and Peptide Institute Inc. (Osaka, Japan).
Clearance studies in the rabbit were performed to check a natriuretic activity of the a-hANP used in this study. Rabbits were anesthetized with pentobarbital (25 mg/kg i.v.), and bicarbonate-Ringer solution (containing 5% inulin) was continuously infused (0.3 ml/min) through the needle inserted into the ear vein. Catheters were placed in the femoral vein and bladder for sampling blood and urine, respectively. After stabilization of urine flow rate, a bolus injection of 20,tg a-hANP was injected into the femoral vein.
RESULTS

Clearance study
A bolus injection of a-hANP immediately increased the urine volume from 64.6 + 15.7 to 173.8 + 25.6 , tl/min (p <0.05), and Na excretion from 6.2 + 1.8 to 22.8 + 3.4, tEq/min (p <0.05) (Fig. 1) . The GFR determined by inulin clearance was also increased from 11.0± 3.8 to 26.4 + 6.7 ml/min (p <0.05). These changes were transient and completed in 10 min. These data clearly demonstrated that a-hANP has a natriuretic potency in the rabbits in vivo.
Effect of a-hANP on J~ and VT Effects of various concentrations (10, 10 -9, 10 -11 M) of bath a-hANP on J,, in SFPST are summarized in Fig. 2 . As shown, 10-' M a-hANP added to the bath did not change J~ significantly. The mean J, for control, a-hANP, and recovery periods were 0.65±0.05, 0.66±0.08, and 0.59±0.08 nl/(mm • min), respectively (n = 8). Mean tubular length was 2.63 + 0.16 mm. Perfusion rate for three consecutive periods were comparable, 11.55±0.57, 12.70±0.84, and 11.82±0.45n1/ min, respectively. Neither 10 -9 M nor 10 -11 M a-hANP changed J~ significantly (Fig.  2) .
Effect of bath a-hANP on J~ was also examined in JMPST. Only the effect of 10-' M of a-hANP was examined. As shown in Fig. 3 , the mean J~ values for control, experimental (a-hANP), and recovery periods were 0.44 + 0.08, 0.45 + 0.06, and 0.38 + 0.07 nl/(mm min),. respectively (n = 7). These values were not significantly different.
The effect on J~ of 10-' M a-hANP added to the lumen was also examined in SFPST (Fig. 4) , and no significant effect was observed. The mean J~ for control, ahANP, and recovery periods were 0.57 + 0.08, 0.66 + 0.07, and 0.68 + 0.10 nl/ (mm • min), respectively (n =12). Table 1 summarizes the response of VT to a-hANP which was added either to the bath or to the lumen; VT was measured as an index of Na reabsorption. As shown in the table, l0 -' M a-hANP added to th bath did not change VT significantly in SFPST or JMPST; neigher did the addition of 10-' M a-hANP into the lumen affect VT significantly in SFPST (Table 1) 
Effect of a-hANP on PAH secretion
Results showing the effect of a-hANP on PAH secretion in SFPST are given in Table 2 , a-hANP (10-v M) added to the bath did not change PAH secretion significantly. The mean rate of PAH secretion for control, a-hANP, and recovery Japanese Journal of Physiology Table 2 are perfusion data using 10 -5 M probenecid in the experimental period. In contrast to a-hANP, probenecid caused a marked inhibition of PAH secretion, in agreement with previous studies (TUNE et al., 1969; WOODHALL et al., 1978) . Thus the techniques used in the present study are sensitive enough to detect inhibition of PAH transport if it occurs.
DISCUSSION
Since the discovery of ANF, the mechanism of natriuresis caused by this peptide has been a central interest to investigators. So far, most of the studies agreed that natriuresis caused by ANF was accompanied by alterations in renal hemodynamics. These alterations included an increase in glomerular filtration rate (GFR) CAMARGO et al., 1984; MAACK et al., 1984; BEASLEY and MALVIN, 1985) , redistribution of intrarenal blood flow (BORENSTEIN'et al., 1983; HIRATA et a1.,1984) , and an increase in renal blood flow (WAKITANI et a!.,1985) . Our clearance study (Fig. 1 ) also showed an increase in GFR. However, these hemodynamic effects do not neglect a direct tubular action of ANF. With respect to a-hANP, it was demonstrated that a low dose of a-hANP produced a significant natriuresis without changing renal hemodynamics, suggesting a direct tubular action of a-hANP (YUKIMURA et al., 1985) .
In this study a direct tubular action of a-hANP was examined in the rabbit PST by in vitro microperfusion technique. In vitro microperfusion technique was used because only this technique allows us to examine PST directly. It is notable that in this technique, secondary effects of the peptide (such as hemodynamic effect) can be avoided. Recent autoradiographic study (KOsEKI et a!.,1986) showed that a-hANP accumulated in the outer stripe of outer-medulla as well as the inner-medulla. The outer stripe of outer-medulla might coincide, with PST, implying the physiologic action of the peptide on this segment, although the authors questioned this possibility.
We could not detect any effect of a-hANP on J~ or VT in the rabbit PST indicating that a-hANP does not alter Na+ transport in this nephron segment. Concentrations of a-hANP examined were 10 -', 10 -9, and 10 -11 M. It is certain that 10 -' M is a pharmacological dose because a blood concentration of this peptide measured by radioimmunoassay was reported to be about 10 _ 9 M in the rat (TANAKA et al., 1984) , and about 10-10 M in the human (GUTOWSKA et al., 1985) . Also, membranes taken from rabbit and rat kidney cortex were demonstrated to have specific binding affinity to this peptide, and its Km was 10 -10 M (NAPIER et al., 1984) .
Our negative results of a-hANP in PST (no change in J~ or VT) are in agreement with recent micropuncture studies examining the effect of ANF on rat proximal convoluted tubules (BRIGGS et al., 1982; SONNENBERG et al., 1982; HUANG et al., 1985) . Those studies reported that ANF did not change, or rather increased ATRIAL   NATRIURETIC  FACTOR  AND  PROXIMAL  TUBULES  89 the proximal reabsorption of volume and solutes in the rat. Very recently, BAUM and ToTo (1986) reported that ANF did not alter the volume reabsorption in the rabbit PST and PCT perfused in vitro. However, in their study, only 10-' M ANF was examined. Our present study examined a more physiological dose of ANF, applied it to the lumen as well as the bath, and also examined the effect on PAH secretion. These negative results suggest that if ANF possesses any direct tubular action, the site of action is not proximal tubules. It may be more distal nephron segments as suggested by micropuncture studies (BRIGGS et al., 1982; SONNENBERS et al., 1982; SONNENBERG, 1985) . There are few studies which have suggested the possibility that proximal tubule is a site of ANF effect. HAMMOND et al. (1985) demonstrated that ANF inhibit a Na +-H + exchange in brush-border membrane vesicles obtained from rat renal cortex, implying the inhibition of HCO3 -reabsorption in the proximal tubules. However, a recent in vivo micropuncture study clearly denied this possibility (HUANG et al., 1985) . BURNETT et al. (1984) reported that ANF increased urinary excretion of phosphate and lithium in the clearance study of the rat, indicating an inhibition of proximal solutes reabsorption. However, these results did not neglect the possibility that ANF changes renal hemodynamics, and thus increases phosphate and lithium excretion.
The effect of a-hANP on PAH secretion was also examined in this study because organic acid secretion is one of the most important function of PST. GRANTHAM et al. (1974) demonstrated that a stimulation of organic acid secretion induced a reduction in volume reabsorption in the rabbit PST. Again, our result ( Table 2) clearly indicated that a-hANP did not alter organic acid secretion in PST. Our basal PAH secretion rate was almost comparable with previous values considering that our tubules included S2 and S3 segments (TUNE et a!., 1969; WOODHALL et a!., 1978) . In summary, our present studies demonstrated that a-hANP increased GFR and Na+ excretion in the rabbit kidney, but did not change volume reabsorption, transepithelial potential difference, or PAH secretion in PST.
